Skip Nav Destination
Article
Zbtb32 promotes CD8+ T cell differentiation and function in cancer
Birui et al. identify Zbtb32 as a key promoter of terminally exhausted CD8+ T cell differentiation, enhancing cell cytotoxicity and anti-tumor function. This study reveals the potential interplay and regulation within CD8+ T cell regulatory network, providing valuable insights for cancer immunotherapy.
